S100P and adenocarcinoma: In our study, the expression of S100P in adenosquamous carcinoma-derived RL95–2 cells was much higher than that in adenocarcinoma-derived Ishikawa cells, which supported Jiang’s opinion that S100P is overexpressed in endometrial adenosquamous carcinomas.